Finally, better elucidation of the mechanisms used by TAMs to facilitate disease progression/metastasis along with thorough characterization of the tumor molecular landscape (i.e. expression of high levels of CD44/visfatin/miR760) could provide alternative targeted therapies for individual patients. This evidence concerns the gene CD44 and neoplasm.